Anthim

Active Ingredient(s): Obiltoxaximab
FDA Approved: * March 18, 2016
Pharm Company: * ELUSYS THERAPEUTICS INC
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Anthim Overview

Obiltoxaximab, sold under the brand name Anthim, is a monoclonal antibody medication designed for the treatment of exposure to Bacillus anthracis spores (etiologic agent of anthrax).[2][1] This drug was developed by Elusys Therapeutics, Inc.[1][3] Contents 1 Society and culture 1.1 Legal status 2 References 3 External links Society and culture Legal status On 17 September 2020, the Committee for Medicinal Products for...

Read more Anthim Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Obiltoxaximab

Recent Anthim Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Anthim: (1 result)

Sorted by National Drug Code

• 69604-204 Anthim 100 mg/ml Intravenous Solution by Elusys Therapeutics, Inc.

Other drugs which contain Obiltoxaximab or a similar ingredient: (1 result)

• OBILTOXAXIMAB